Research graph
References from Baseline Extracellular HMGB-1 Levels Associated with Induction Chemotherapy Response in Adult Acute Myeloid Leukemia. Local targets link to admitted publications; unresolved targets remain external evidence.
Association of leukocyte nadir with complete remission in Indonesian acute myeloid leukemia patients undergoing 7+3 remission induction chemotherapy.
10.12688/f1000research.110320.1 · 2022 · External reference
Acute myeloid leukemia: 2025 update on diagnosis, risk-stratification, and management.
10.1002/ajh.27625 · 2025 · External reference
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN.
10.1182/blood.2022016867 · 2022 · External reference
What Is the Best Daunorubicin Dose and Schedule for Acute Myeloid Leukemia Induction?
10.1007/s11864-017-0446-4 · 2017 · External reference
ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response.
10.1016/j.molcel.2017.05.015 · 2017 · External reference
ATR-CHK1 pathway as a therapeutic target for acute and chronic leukemias.
10.1016/j.ctrv.2020.102026 · 2020 · External reference
Incidence, presentation, and prognosis of malignancies in ataxia-telangiectasia: a report from the French national registry of primary immune deficiencies.
10.1200/jco.2014.56.5101 · 2015 · External reference
Cancer risks and mortality in heterozygous ATM mutation carriers.
10.1093/jnci/dji141 · 2005 · External reference
MicroRNA-181 as a prognostic biomarker for survival in acute myeloid leukemia: a meta-analysis.
10.18632/oncotarget.19195 · 2017 · External reference
The genesis and evolution of acute myeloid leukemia stem cells in the microenvironment: From biology to therapeutic targeting.
10.1038/s41420-022-01193-0 · 2022 · External reference
The many faces of HMGB1: molecular structure-functional activity in inflammation, apoptosis, and chemotaxis.
10.1189/jlb.1212662 · 2013 · External reference
Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists.
10.1038/cdd.2013.72 · 2014 · External reference
Methods for measuring HMGB1 release during immunogenic cell death.
10.1016/bs.mie.2019.05.001 · 2019 · External reference
Interplay between RAGE and TLR4 regulates HMGB1-induced inflammation by promoting cell surface expression of RAGE and TLR4.
10.4049/jimmunol.1900860 · 2020 · External reference
Prognostic Factors of Acute Myelocytic Leukemia: An Analysis of 132 patients in a Single Institution.
10.3346/jkms.1996.11.3.222 · 1996 · External reference
Clinical features and outcome of acute myeloid leukemia, a single institution experience in Saudi Arabia.
10.4103/1658-5127.155171 · 2015 · External reference
Frequency of complete remission after standard 3+7 induction therapy in patients with acute myeloid leukemia.
10.12669/pjms.38.5.5249 · 2022 · External reference
Clinicohematological Parameters and Assessment of Post Induction Status in Acute Myeloid Leukemia–Experience at A Tertiary Care Center.
10.51253/pafmj.v72i1.5405 · 2022 · External reference
High Mobility Group Box-1 (HMGB-1): A Potential Target in Therapeutics.
10.2174/1389450120666190618125100 · 2019 · External reference
Enlightening the role of high mobility group box 1 (HMGB-1) in inflammation: Updates on receptor signalling.
10.1016/j.ejphar.2019.172487 · 2019 · External reference
Multiple functions of HMGB-1 in cancer.
10.3389/fonc.2024.1384109 · 2024 · External reference
High-mobility group box 1 and cancer.
10.1016/j.bbagrm.2009.11.014 · 2010 · External reference
HMGB-1: an important regulator of myeloid differentiation and acute myeloid leukemia as well as a promising therapeutic target.
10.1007/s00109-020-01998-5 · 2021 · External reference
Up-regulated autophagy by endogenous high mobility group box-1 promotes chemoresistance in leukemia cells.
10.3109/10428194.2011.616962 · 2012 · External reference
HMGB-1 translocation is involved in the transformation of autophagy complexes and promotes chemoresistance in leukaemia.
10.3892/ijo.2015.2985 · 2015 · External reference
High mobility group box 1 (HMGB-1): a pivotal regulator of hematopoietic malignancies.
10.1186/s13045-020-00920-3 · 2020 · External reference
Mechanisms involved in the HMGB-1 modulation of tumor multidrug resistance (Review).
10.3892/ijmm.2023.5272 · 2023 · External reference
The receptor for advanced glycation end products (RAGE) enhances autophagy and neutrophil extracellular traps in pancreatic cancer.
10.1038/cgt.2015.21 · 2015 · External reference
Role of microRNAs, circRNAs and long noncoding RNAs in acute myeloid leukemia.
10.1186/s13045-019-0734-5 · 2019 · External reference
HMGB-1-induced autophagy promotes chemotherapy resistance in leukemia cells.
10.1038/leu.2010.225 · 2011 · External reference
Immunogenic effects of chemotherapy-induced tumor cell death.
10.1016/j.gendis.2018.05.003 · 2018 · External reference
Stimulators of immunogenic cell death for cancer therapy: focusing on natural compounds.
10.1186/s12935-023-03058-7 · 2023 · External reference
Immunogenic Cell Death: A Step Ahead of Autophagy in Cancer Therapy.
10.33696/cancerimmunol.3.041 · 2021 · External reference
